ASX ANNOUNCEMENT
Vita Group Limited
ACN 113 178 519
77 Hudson Road
Albion Qld 4010
25 February 2022
Market Announcements Office
Australian Securities Exchange
4th Floor, 20 Bridge Street
SYDNEY NSW 2000
ELECTRONIC LODGEMENT
Dear Sir or Madam
Vita Group Limited - Financial Results for the half-year ended 31 December 2021 - CEO/CFO Analyst Briefing Presentation and Materials
In accordance with the Listing Rules, please find enclosed for immediate release to the market:
- an announcement 'Vita Group delivers interim revenues in line with guidance'; and
- a presentation.
Vita will conduct an analyst briefing on its half-year results from 9:00am AEST.
This announcement has been authorised for lodgement by VTG's Board of Directors.
For enquiries relating to this announcement, contact:
Andrew Ryan | George Southgate |
Chief Financial Officer | Chief Legal and Risk Officer / Company Secretary |
Mob: 0417 644 756 | Mob: 0412 514 030 |
Yours sincerely |
George Southgate
Chief Legal and Risk Officer / Company Secretary
Vita Group Limited
ASX ANNOUNCEMENT
Friday, 25 February 2022
Vita Group delivers interim revenues in line with guidance
Vita Group (ASX: VTG) today announced reported interim revenues from continuing operations of $12.6 million for the six months to 31 December 2021, a 16 per cent decrease on prior year, in line with guidance issued to the market on 26 November 2021. EBITDA1 from continuing operations was a loss of $3.7 million. After excluding a once-off gain on contingent consideration, underlying EBITDA was a loss of $4.2 million. Group NPAT2 was a loss of $1.7 million, which included NPAT from discontinued operations of $1.7 million. Group NPAT included a preliminary gain on sale of ICT3 of $2.6 million which remains subject to finalisation of exit costs and post-completion adjustments.
($m unless otherwise stated) | H1 FY22 | ||||
Revenue | 12.6 | ||||
Continuing Operations | EBITDA | (3.7) | |||
Underlying EBITDA | (4.2) | ||||
(Artisan) | |||||
EBIT4 | (5.1) | ||||
NPAT | (3.4) | ||||
Discontinued Operations | Revenue | 178.9 | |||
(ICT) 1 Jul 21 - 12 Nov 21 | NPAT | 1.7 | |||
Group | NPAT | (1.7) |
The period marked a major transition for Vita as it finalised the divestment of its ICT business to Telstra Corporation Limited (Telstra). Vita received settlement funds in the amount of $107.4 million ($110 million cash consideration less net working capital, net-debt adjustments, and including tax exit consideration as at 30 September 20215), subject to final adjustments. The first tranche of the fully franked Special Dividend, being $0.39 cents per share (equating to $64.6 million), was paid to eligible shareholders on 26 November 2021.
Vita ended the period with net cash of $43.6 million. Operating cash outflows from continuing operations after tax were $4.4 million. Investing cash outflows included $1.0 million of capital expenditure directed towards the purchase of aesthetic equipment, and $2.0 million placed as a security term deposit. Net financing cash outflows were $69.8 million, reflecting lease payments of $1.6 million, net debt drawdowns of $0.3 million, and dividends paid of $68.6 million, including the final FY21 fully franked dividend of $4.0 million. Net cash inflows from discontinued operations including the proceeds from sale amounted to $84.3 million.
The Board has determined not to pay an interim dividend for H1 FY22, electing to utilise Vita's current position to invest in the Artisan business. The Board expects that the final tranche of the Special Dividend relating to the ICT divestment (approximately $0.03 to $0.06 cents per share equating to $5 million to $10 million) will be paid in H2 FY22, subject to finalisation of exit costs and post-completion adjustments. As announced on 12 November 2021, Vita's dividend reinvestment plan (DRP) continues to remain suspended and will not operate for the final tranche of the Special Dividend.
H1 FY22 in review
The first half of FY22 was an extraordinary and transformational period for Vita. Whilst the group continued to navigate COVID-19 impacts, Vita finalised the divestment and transition of its retail ICT business, including Sprout, to Telstra. The divestment involved a significant amount of work and focus by management and the Vita team to deliver an outcome intended to be in the best interests of all stakeholders, including negotiation, due diligence, change and transition management, and the establishment of new support IT infrastructure for the ongoing business.
Like-for-like Artisan revenues were down 22 per cent, primarily as a result of government-mandated lockdowns, in particular extended lockdowns in NSW, Victoria, and the ACT, which forced the closure of many of Artisan's largest clinics between July and mid-October 2021. In total, Artisan lost over 500 - approximately 21 per cent - trading days throughout the period. Artisan also experienced impacts from higher than expected loss of team members in Queensland.
-
Earnings before interest, tax, depreciation, and amortisation. A pre-AASB-16 measure. Includes full allocation of corporate overheads.
2 Net profit / (loss) after tax.
3 Information and communication technology business, including Sprout accessory business.
4 Earnings before interest and tax. Includes full allocation of corporate overheads.
5 See VTG announcement dated 24 September 2021, Sale of Vita Group's Retail ICT and Sprout business to Telstra, Annexure A relating to locked box mechanism.
Prior to the finalisation of the ICT transaction, the ICT business also experienced a reduction in revenue resulting from COVID-19 related impacts including store closures, reduced foot traffic, social distancing capacity constraints, and an increase in service related transactions.
Focus on Artisan - early in its lifecycle
Vita's sole focus now is its Artisan business. Having entered the industry in November 2017, and launching the Artisan brand in October 2018, the business remains early in its lifecycle. With the disruption of the ICT business sale and transition now largely behind it, Vita is well positioned to execute on its priority to organically grow Artisan. Additionally, Vita will optimise, and continue to rebrand its non-Artisan branded clinics, and expand through greenfield openings and prudent acquisitions. Vita intends to leverage the following strengths:
- Artisan's premium positioning and brand promise: Master The Artistry Of You®
- Vita's disciplined processes and team culture, both of which draw on its clinical expertise and client- centric consulting skills
- Expertise and capability in operationalising and scaling retail businesses
- Investments in advanced modality technologies within bespoke and premium destination clinics
- Developed intellectual property, including its proprietary software cosmedcloud®
Additionally, being a premium 100 per cent owned business model, Vita enjoys direct engagement and relationships with its team members, which enables:
- Development of team member capability and experiences, aligning to Vita's ambition of being an employer of choice within the SHAW industry
- Consistent delivery of premium client experiences, focused on high quality and safe outcomes
- Efficient execution of business development and clinical governance programs in a highly disciplined and effective manner
Vita's priority is to grow Artisan organically and sustainably, leveraging Vita's strengths to enhance:
- Artisan's brand awareness, offering, and degree of standardisation
- Client value creation through holistic and individualised treatment plans and high standards of service
- Team member experiences, with emphasis on capability, skills expansion, and career development
- Risk and clinical governance frameworks
- Leadership development and executional frameworks
- Business tools and efficiency processes and programs
Outlook
The Omicron variant of COVID-19 has reintroduced some short-term uncertainty and headwinds, with team and client vaccination, and isolation requirements continuing to disrupt trade. However, the medium and long- term growth prospects of the SHAW industry is strong with increasing awareness and demand for an evolving range of treatments and services. The SHAW industry is also fragmented with many market participants, which is likely to present consolidation opportunities, particularly as Vita anticipates an increase in industry regulation. These factors, combined with Vita's strengths and execution of operational priorities, represent significant growth potential.
Chief Executive Officer, Pete Connors commented: "The past 6-12 months has been an extraordinary period in Vita's history. I would like to thank everyone involved for their professionalism and efforts and convey my best wishes to both the old Vita ICT team and to Telstra in their future endeavours. With a great team, solid business foundations in place, and the ability to leverage our investments and strengths, I'm excited to lead the business and am confident that we are well positioned to achieve our growth ambitions. I'd also like to express my thanks to the Vita and Artisan teams who have demonstrated resilience and commitment whilst maintaining their focus throughout a challenging period on delivering exceptional client outcomes."
This announcement has been authorised for lodgement by VTG's Board of Directors.
Further enquiries: | |
Andrew Ryan | George Southgate |
Chief Financial Officer | Chief Legal and Risk Officer / Company Secretary |
Mob: 0417 644 756 | Mob: 0412 514 030 |
H1 FY22 RESULTS
2 5 F E B R U A R Y 2 0 2 2
Authorised for release by the VTG Board
H1 FY22 HEADLINES
Performance
CONTINUING OPERATIONS
Revenues
$12.6m, down 16%
- In line with guidance
- COVID-19impacts
Underlying EBITDA1 | NPAT2 |
($4.2m), down 31% | ($3.4m), down 26% |
TOTALRevenues
GROUP$191.5m
DISCONTINUED OPERATIONS
Revenues
$178.9m, down 43%
- 1 Jul - 12 Nov 21
- COVID-19impacts
NPAT2
$1.7m divested 12 November 2021
Includes preliminary gain on sale of ICT of $2.6m
NPAT2
($1.7m)
- Pre-AASB16. Includes full corporate overhead allocation and once-off gain on contingent consideration; H1 FY21 comparative excludes JobKeeper receipts and includes full corporate overhead allocation
- Includes full corporate overhead allocation
H1 FY22 Results Presentation Vita Group Limited | 2
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Vita Group Limited published this content on 25 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 February 2022 22:27:17 UTC.